Please provide your email address to receive an email when new articles are posted on . About 75% of cases are the result of damage to parathyroid glands during neck surgery. The other 25% of cases ...

Please provide your email address to receive an email when new articles are posted on . Adults with hypoparathyroidism had worse processing speed and visual and auditory memory than healthy controls.

Dawn Ethier, a police officer in Ottawa, Canada, recalls how her life revolved around managing her 100-pill-a-day regimen. Her symptoms began 3 weeks after her thyroid surgery, but it took another 4 ...

Results showed eneboparatide compared with placebo met the primary endpoint with statistical significance at 24 weeks. Topline data were announced from a phase 3 trial evaluating eneboparatide in ...

"Until now, the only treatment option for adults with chronic hypoparathyroidism has been conventional therapy with calcium and active vitamin D supplementation to keep blood calcium levels normal," ...

COPENHAGEN, Denmark, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that YORVIPATH® (palopegteriparatide; developed as TransCon PTH) is now commercially available ...

In a phase 2 trial, 93% of eneboparatide-treated patients were able to discontinue standard of care therapy. The Food and Drug Administration (FDA) has granted Fast Track designation to eneboparatide ...